| 标题 |
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study) |
| 网址 | |
| DOI |
10.1097/cce.0000000000000577
doi
|
| 其它 |
期刊:Critical Care Explorations 作者:M. Bauer; A. Weyland; G. Marx; F. Bloos; S. Weber; et al 出版日期:2021-11-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)